Stock CONTEXT THERAPEUTICS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Relative Strength Chart Context Therapeutics Inc. Nasdaq

Equities

US21077P1084

Market Closed - Nasdaq
Other stock markets
 01:30:00 17/07/2024 am IST 		5-day change 1st Jan Change
2.19 USD -0.45% Intraday chart for Context Therapeutics Inc. +12.89% +93.81%
08/05 Context Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
06/05 Context Therapeutics Inc. announced that it has received $99.992767 million in funding from Ally Bridge Group, Avidity Partners, LLC, Blue Owl Healthcare Opportunities, Deep Track Capital, LP, Driehaus Capital Management LLC, Great Point Partners, LLC CI

End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
CONTEXT THERAPEUTICS INC.
Other Biotechnology & Medical Research
-0.45%+12.89% - - - 16Cr - - -
  1. Stock Market
  2. Equities
  3. Stock
  4. Stock
  5. Charts Context Therapeutics Inc.
  6. Relative Strength Chart